Conquering Diseases

Study Of An Investigational Drug To Treat Advanced Melanoma

Description

Seeking men and women with advanced (Stage III or IV) melanoma for a study of whether adding an investigational drug to an FDA approved drug combination is safe and effective.

Overview

We are studying whether adding an investigational drug to the usual drug combination is safe and improves the therapy's antitumor effects. Participants will be randomly assigned to receive the usual drug combination alone or the usual drub combination and the investigational drug.

What we're hoping for

We hope that adding the investigational drug to usual FDA approved drug combination for advanced melanoma will be safe and improve the therapy's antitumor effects.

Additional Information

ClinicalTrials.gov Identifier: NCT02339571

 Principal Investigator

Tasneem  Ali, MD

UMass Memorial Health Care

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMMS University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989